Endo Strikes Mylan With Suit Over Generic Frova
Endo Pharmaceuticals Inc. sued Mylan Inc. and its subsidiary in Delaware federal court Tuesday to block the marketing of a generic version of its migraine medication Frova....To view the full article, register now.
Already a subscriber? Click here to view full article